AU2012308530B2 - Products for healing of tissue wounds - Google Patents

Products for healing of tissue wounds Download PDF

Info

Publication number
AU2012308530B2
AU2012308530B2 AU2012308530A AU2012308530A AU2012308530B2 AU 2012308530 B2 AU2012308530 B2 AU 2012308530B2 AU 2012308530 A AU2012308530 A AU 2012308530A AU 2012308530 A AU2012308530 A AU 2012308530A AU 2012308530 B2 AU2012308530 B2 AU 2012308530B2
Authority
AU
Australia
Prior art keywords
unsubstituted
alkyl
substituted
group
alkylamino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2012308530A
Other languages
English (en)
Other versions
AU2012308530A1 (en
Inventor
Carl GENBERG
Paul B. Savage
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Brigham Young University
Original Assignee
Brigham Young University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brigham Young University filed Critical Brigham Young University
Publication of AU2012308530A1 publication Critical patent/AU2012308530A1/en
Application granted granted Critical
Publication of AU2012308530B2 publication Critical patent/AU2012308530B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2012308530A 2011-09-13 2012-09-13 Products for healing of tissue wounds Active AU2012308530B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161534194P 2011-09-13 2011-09-13
US61/534,194 2011-09-13
PCT/US2012/055248 WO2013040269A1 (en) 2011-09-13 2012-09-13 Products for healing of tissue wounds

Publications (2)

Publication Number Publication Date
AU2012308530A1 AU2012308530A1 (en) 2014-04-03
AU2012308530B2 true AU2012308530B2 (en) 2016-04-21

Family

ID=47071446

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2012308526A Active AU2012308526B2 (en) 2011-09-13 2012-09-13 Compositions for treating bone diseases and broken bones
AU2012308530A Active AU2012308530B2 (en) 2011-09-13 2012-09-13 Products for healing of tissue wounds

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU2012308526A Active AU2012308526B2 (en) 2011-09-13 2012-09-13 Compositions for treating bone diseases and broken bones

Country Status (12)

Country Link
US (1) US9161942B2 (enExample)
EP (1) EP2760454B1 (enExample)
JP (1) JP6038155B2 (enExample)
KR (1) KR101966293B1 (enExample)
CN (1) CN104080458B (enExample)
AU (2) AU2012308526B2 (enExample)
BR (1) BR112014005914B1 (enExample)
CA (1) CA2848567C (enExample)
IL (1) IL231509B (enExample)
MX (1) MX369385B (enExample)
RU (1) RU2652308C2 (enExample)
WO (2) WO2013040265A1 (enExample)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2303026B1 (en) 2008-06-17 2020-09-09 Brigham Young University Cationic steroid antimicrobial diagnostic, detection, screening and imaging methods
EP2734246B1 (en) 2011-07-20 2019-02-27 Brigham Young University Hydrophobic ceragenin compounds and devices incorporating same
US8945217B2 (en) 2011-08-25 2015-02-03 Brigham Young University Medical devices incorporating ceragenin-containing composites
CA2852989C (en) 2011-09-13 2021-06-29 Brigham Young University Compositions for treating bone diseases and broken bones
US9694019B2 (en) 2011-09-13 2017-07-04 Brigham Young University Compositions and methods for treating bone diseases and broken bones
US9603859B2 (en) 2011-09-13 2017-03-28 Brigham Young University Methods and products for increasing the rate of healing of tissue wounds
MX2014007496A (es) 2011-12-21 2015-02-17 Univ Brigham Young Composiciones para el cuidado oral.
US9533063B1 (en) 2012-03-01 2017-01-03 Brigham Young University Aerosols incorporating ceragenin compounds and methods of use thereof
CA2872399C (en) 2012-05-02 2021-01-12 Brigham Young University Ceragenin particulate materials and methods for making same
US9314472B2 (en) 2012-10-17 2016-04-19 Brigham Young University Treatment and prevention of mastitis
EP2941253B1 (en) 2013-01-07 2021-08-11 Brigham Young University Cationic steroid antimicrobial agents for use in treating cancer
JP6518230B2 (ja) 2013-03-15 2019-05-22 ブリガム・ヤング・ユニバーシティＢｒｉｇｈａｍ Ｙｏｕｎｇ Ｕｎｉｖｅｒｓｉｔｙ 炎症、自己免疫疾患、および疼痛を治療する方法
US10568893B2 (en) 2013-03-15 2020-02-25 Brigham Young University Methods for treating inflammation, autoimmune disorders and pain
US11524015B2 (en) 2013-03-15 2022-12-13 Brigham Young University Methods for treating inflammation, autoimmune disorders and pain
US9387215B2 (en) 2013-04-22 2016-07-12 Brigham Young University Animal feed including cationic cholesterol additive and related methods
US11690855B2 (en) 2013-10-17 2023-07-04 Brigham Young University Methods for treating lung infections and inflammation
US20150203527A1 (en) * 2014-01-23 2015-07-23 Brigham Young University Cationic steroidal antimicrobials
CA2844321C (en) 2014-02-27 2021-03-16 Brigham Young University Cationic steroidal antimicrobial compounds
US10220045B2 (en) 2014-03-13 2019-03-05 Brigham Young University Compositions and methods for forming stabilized compositions with reduced CSA agglomeration
US9867836B2 (en) 2014-03-13 2018-01-16 Brigham Young University Lavage and/or infusion using CSA compounds for increasing fertility in a mammal
US9931350B2 (en) 2014-03-14 2018-04-03 Brigham Young University Anti-infective and osteogenic compositions and methods of use
US9686966B2 (en) 2014-04-30 2017-06-27 Brigham Young University Methods and apparatus for cleaning or disinfecting a water delivery system
US10441595B2 (en) * 2014-06-26 2019-10-15 Brigham Young University Methods for treating fungal infections
US10238665B2 (en) 2014-06-26 2019-03-26 Brigham Young University Methods for treating fungal infections
US10227376B2 (en) 2014-08-22 2019-03-12 Brigham Young University Radiolabeled cationic steroid antimicrobials and diagnostic methods
US10155788B2 (en) 2014-10-07 2018-12-18 Brigham Young University Cationic steroidal antimicrobial prodrug compositions and uses thereof
CN108348484B (zh) * 2015-04-22 2021-12-17 布莱阿姆青年大学 阳离子甾体抗微生物盐
WO2016172553A1 (en) 2015-04-22 2016-10-27 Savage Paul B Methods for the synthesis of ceragenins
WO2016172543A1 (en) 2015-04-22 2016-10-27 Savage Paul B Methods for the synthesis of ceragenins
AU2016250816B2 (en) * 2015-04-22 2020-10-22 Brigham Young University Cationic steroidal antimicrobial salts
US9434759B1 (en) * 2015-05-18 2016-09-06 Brigham Young University Cationic steroidal antimicrobial compounds and methods of manufacturing such compounds
US20170080128A1 (en) * 2015-09-21 2017-03-23 Brigham Young University Novel endotracheal tube for the reduction of intubation-related complication in neonates and babies
US10226550B2 (en) 2016-03-11 2019-03-12 Brigham Young University Cationic steroidal antimicrobial compositions for the treatment of dermal tissue
US10959433B2 (en) 2017-03-21 2021-03-30 Brigham Young University Use of cationic steroidal antimicrobials for sporicidal activity
KR101792535B1 (ko) 2017-09-27 2017-11-02 오상자이엘 주식회사 화상 치료용 키트
US12186328B2 (en) * 2019-05-23 2025-01-07 Brigham Young University Use of CSA compounds to stimulate stem cells and hair growth

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007089906A2 (en) * 2006-02-01 2007-08-09 Brigham Young University Cationic steroid antimicrobial compositions for treating or preventing herpes infections
US7754705B2 (en) * 2006-02-01 2010-07-13 Brigham Young University Cationic steroid antimicrobial compositions and methods of use

Family Cites Families (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US428800A (en) * 1890-05-27 miller
US4661341A (en) 1984-10-30 1987-04-28 The Procter & Gamble Company Oral compositions
US4842593A (en) 1987-10-09 1989-06-27 The Procter & Gamble Company Disposable absorbent articles for incontinent individuals
US4865855A (en) 1988-01-11 1989-09-12 Kimberly-Clark Corporation Antimicrobial absorbent food pad
US4990338A (en) 1988-05-09 1991-02-05 Dow Corning Corporation Antimicrobial superabsorbent compositions and methods
US5356630A (en) 1989-02-22 1994-10-18 Massachusetts Institute Of Technology Delivery system for controlled release of bioactive factors
US4972848A (en) 1989-08-23 1990-11-27 Medtronic, Inc. Medical electrical lead with polymeric monolithic controlled release device and method of manufacture
GB9020075D0 (en) 1990-09-14 1990-10-24 Filler Aaron G Contrast agents for magnetic resonance imaging of axonal transport
US5286479A (en) 1991-12-10 1994-02-15 The Dow Chemical Company Oral compositions for suppressing mouth odors
DE69427469T2 (de) 1993-03-12 2001-10-31 Pharmacia & Upjohn Co., Kalamazoo Kristallines ceftiofur (freie säure)
DE69429364T2 (de) 1994-03-10 2002-08-08 Magainin Pharmaceuticals,Inc. Verwendung von steroidderivaten als arzneimittel
US6132765A (en) 1996-04-12 2000-10-17 Uroteq Inc. Drug delivery via therapeutic hydrogels
ES2229376T5 (es) * 1996-07-22 2010-10-25 Renovo Limited Uso de compuestos que promueven la actividad estrogenica para acelerar la cicatrizacion de las heridas de la piel.
US6767904B2 (en) 1998-03-06 2004-07-27 Bringham Young University Steroid derived antibiotics
US6350738B1 (en) 1998-03-06 2002-02-26 Brigham Young University Steroid derived antibiotics
BR9815711B1 (pt) 1998-03-06 2014-10-29 Univ Brigham Young Composto antibiótico derivado de esteróide
US6667299B1 (en) 2000-03-16 2003-12-23 Hollis-Eden Pharmaceuticals, Inc. Pharmaceutical compositions and treatment methods
US6673771B1 (en) 1999-07-28 2004-01-06 The Trustees Of The University Of Pennsylvania Methods of inhibiting osteoclast activity
US6551608B2 (en) 2000-03-06 2003-04-22 Porex Technologies Corporation Porous plastic media with antiviral or antimicrobial properties and processes for making the same
EP1311531B1 (en) 2000-08-15 2016-05-11 Brigham Young University Steroid derived antibiotics
US6514556B2 (en) 2000-12-15 2003-02-04 Ecolab Inc. Method and composition for washing poultry during processing
US9056048B2 (en) * 2001-08-16 2015-06-16 The Trustees Of The University Of Pennsylvania Synthesis and use of cationic steroids for anti-inflammatory drug therapy
JP5170934B2 (ja) * 2001-08-16 2013-03-27 ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア 改良ｄｎａリポフェクションならびに／または徐放性プロドラッグおよび薬物療法のための試薬の合成と使用
US6939376B2 (en) 2001-11-05 2005-09-06 Sun Biomedical, Ltd. Drug-delivery endovascular stent and method for treating restenosis
DE10218147B4 (de) 2002-04-23 2005-12-22 Stockhausen Gmbh Wasserabsorbierende, die Zersetzung von Körperflüssigkeiten verzögernde Polymerteilchen, deren Herstellung und Verwendung
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US7659061B2 (en) 2002-11-19 2010-02-09 Pharmacia & Upjohn Company Pharmaceutical compositions having a modified vehicle
US7282214B2 (en) 2002-12-19 2007-10-16 Johnson & Johnson Vision Care, Inc. Biomedical devices with antimicrobial coatings
EP1638620B2 (en) 2003-06-23 2018-04-25 Beiersdorf AG Antimicrobial wounddressing
GB0318901D0 (en) 2003-08-12 2003-09-17 Univ Bath Improvements in or relating to bone substitute material
US20050267051A1 (en) 2003-12-19 2005-12-01 Lee Henry J Antineoplastic and anti-HIV conjugates of steroid acid and nucleosides
US8119154B2 (en) 2004-04-30 2012-02-21 Allergan, Inc. Sustained release intraocular implants and related methods
US20060062742A1 (en) 2004-09-21 2006-03-23 The Procter & Gamble Company Compositions for reduction of human malodor
US20070191322A1 (en) 2006-02-01 2007-08-16 Savage Paul B Cationic Steroid Microbial Compositions and Methods of Use
CN101378761B (zh) 2006-02-01 2013-10-16 杨百翰大学 阳离子类固醇抗微生物剂组合物及其使用方法
WO2007134176A2 (en) 2006-05-10 2007-11-22 Microban Products Company Antimicrobial food pad
US7858000B2 (en) 2006-06-08 2010-12-28 Novartis Ag Method of making silicone hydrogel contact lenses
WO2008006083A2 (en) 2006-07-07 2008-01-10 Surmodics, Inc. Beaded wound spacer device
KR100950204B1 (ko) 2006-09-26 2010-03-29 경북대학교 산학협력단 7α-아미노스테로이드 유도체 또는 이의 약학적으로허용가능한 염, 이의 제조방법 및 이를 유효성분으로함유하는 항암용 또는 항생제 조성물
US7854941B2 (en) 2007-02-12 2010-12-21 The University Of Southern Mississippi Method of attaching drug compounds to non-reactive polymer surfaces
US20090016973A1 (en) 2007-07-09 2009-01-15 Micropure, Inc. Composition and Method for the Prevention of Oral Disease
US20090068122A1 (en) 2007-09-06 2009-03-12 Shira Pilch Dentifrice Compositions for Treating Xerostomia
EP2197457A4 (en) 2007-09-26 2010-10-27 Aparna Biosciences THERAPEUTIC VACCINE POLYELECTROLYTE NANOPARTICLE COMPOSITIONS
EP2303026B1 (en) 2008-06-17 2020-09-09 Brigham Young University Cationic steroid antimicrobial diagnostic, detection, screening and imaging methods
US20090324517A1 (en) 2008-06-30 2009-12-31 Dan Kline Halitosis treatment
JP2012532889A (ja) * 2009-07-09 2012-12-20 クレッシェンド セラピューティクス、エルエルシー 創傷治療方法及び傷跡変性方法
WO2011066260A2 (en) 2009-11-25 2011-06-03 Michael Zasloff Formulations comprising aminosterols
US8557031B1 (en) * 2010-01-07 2013-10-15 Sandia Corporation Methods for attaching polymerizable ceragenins to water treatment membranes using amine and amide linkages
EP2542245A4 (en) * 2010-03-04 2013-08-14 Univ Pennsylvania ANTIMICROBIAL CATIONIC STEROIDS AND METHOD FOR THEIR USE
US8871716B2 (en) * 2010-10-08 2014-10-28 Korea Advanced Institute Of Science And Technology Use of antimicrobial peptides in regeneration of skin cells
CA2816879C (en) 2010-11-03 2019-06-11 Paul B. Savage Storage-stable, anti-microbial compositions including ceragenin compounds and methods of use
CN102172356B (zh) * 2011-03-03 2013-04-03 山东农业大学 牛磺鹅去氧胆酸在制备防治骨质疏松的药物中的应用
US8810380B2 (en) 2011-07-01 2014-08-19 Gerald F. Leitz Golf scoring management system
EP2734246B1 (en) 2011-07-20 2019-02-27 Brigham Young University Hydrophobic ceragenin compounds and devices incorporating same
US8945217B2 (en) 2011-08-25 2015-02-03 Brigham Young University Medical devices incorporating ceragenin-containing composites
WO2013029059A1 (en) 2011-08-25 2013-02-28 Brigham Young University Medical devices incorporating ceragenin-containing composites
WO2013029055A1 (en) 2011-08-25 2013-02-28 Brigham Young University Incorporation of particulate ceragenins in polymers
MX2014007496A (es) 2011-12-21 2015-02-17 Univ Brigham Young Composiciones para el cuidado oral.
EP2819531B1 (en) 2012-03-01 2016-01-20 Brigham Young University Anti-microbial food processing compositions including ceragenin compounds and methods of use
US20130280391A1 (en) 2012-04-24 2013-10-24 Brigham Young University Anti-microbial wash compositions including ceragenin compounds and methods of use for treating non-meat food products
US9314472B2 (en) 2012-10-17 2016-04-19 Brigham Young University Treatment and prevention of mastitis
EP2941253B1 (en) 2013-01-07 2021-08-11 Brigham Young University Cationic steroid antimicrobial agents for use in treating cancer
JP6518230B2 (ja) 2013-03-15 2019-05-22 ブリガム・ヤング・ユニバーシティＢｒｉｇｈａｍ Ｙｏｕｎｇ Ｕｎｉｖｅｒｓｉｔｙ 炎症、自己免疫疾患、および疼痛を治療する方法
US9387215B2 (en) 2013-04-22 2016-07-12 Brigham Young University Animal feed including cationic cholesterol additive and related methods

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007089906A2 (en) * 2006-02-01 2007-08-09 Brigham Young University Cationic steroid antimicrobial compositions for treating or preventing herpes infections
US7754705B2 (en) * 2006-02-01 2010-07-13 Brigham Young University Cationic steroid antimicrobial compositions and methods of use

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
GUAN, Q., ET AL., "Preparation and Characterization of Cholic Acid-Derived Antimicrobial Agents with Controlled Stabilities". Organic Letters, 2000, vol. 2, no. 18, pages 2837-2840 *
Howell, MD et al (2009) Journal of Investigative Dermatology 129: 2668-2675 *
Isogai, E et al (2009) Oral Microbiology Immunology 24: 170-172 *
Leszczynska, K et al (2010) Journal of Applied Microbiology 110: 229-238 *
Van Bambeke, F et al (2008) Trends in Pharmacological Sciences 29: 124-134 *

Also Published As

Publication number Publication date
AU2012308526B2 (en) 2016-04-21
RU2652308C2 (ru) 2018-04-25
US20130243823A1 (en) 2013-09-19
MX2014003020A (es) 2014-10-14
EP2760454A1 (en) 2014-08-06
AU2012308526A1 (en) 2014-04-03
JP6038155B2 (ja) 2016-12-07
JP2014530192A (ja) 2014-11-17
IL231509A0 (en) 2014-04-30
IL231509B (en) 2019-02-28
BR112014005914B1 (pt) 2021-11-09
KR101966293B1 (ko) 2019-04-08
AU2012308530A1 (en) 2014-04-03
MX369385B (es) 2019-11-07
CN104080458A (zh) 2014-10-01
BR112014005914A2 (pt) 2017-06-13
CA2848567C (en) 2020-03-24
EP2760454B1 (en) 2018-08-29
RU2014112784A (ru) 2015-10-20
CA2848567A1 (en) 2013-03-21
WO2013040269A1 (en) 2013-03-21
KR20140075729A (ko) 2014-06-19
CN104080458B (zh) 2020-06-02
US9161942B2 (en) 2015-10-20
WO2013040265A1 (en) 2013-03-21

Similar Documents

Publication Publication Date Title
AU2012308530B2 (en) Products for healing of tissue wounds
US9603859B2 (en) Methods and products for increasing the rate of healing of tissue wounds
CA2852989C (en) Compositions for treating bone diseases and broken bones
CA2953136C (en) Methods for treating fungal infections
CA2907082C (en) Methods for treating inflammation, autoimmune disorders and pain
US20150366880A1 (en) Compositions and methods for treating bone diseases and broken bones

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)